Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	90393
Country	China

Received	2023-12-03 08:20
Peer-Review Started	2023-12-03 08:20
To Make the First Decision
Return for Revision	2024-01-15 06:11
Revised	2024-01-25 11:18
Second Decision	2024-02-18 01:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-02-18 05:01
Articles in Press	2024-02-18 05:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-23 23:27
Publish the Manuscript Online	2024-05-09 13:59

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome
Manuscript Source	Unsolicited Manuscript
All Author List	Fan Mu, Liang-Shuo Hu, Kun Xu, Zhen Zhao, Bai-Cai Yang, Yi-Meng Wang, Kun Guo, Jian-Hua Shi, Yi Lv and Bo Wang
ORCID	Author(s) ORCID Number Fan Mu http://orcid.org/0000-0001-8095-7424 Liang-Shuo Hu http://orcid.org/0000-0001-8288-592X Zhen Zhao http://orcid.org/0000-0002-0897-6871 Kun Guo http://orcid.org/0000-0002-0277-2181 Jian-Hua Shi http://orcid.org/0000-0001-8699-6790 Bo Wang http://orcid.org/0000-0001-5813-1810
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 82070649
Corresponding Author	Bo Wang, PhD, Chief Doctor, Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, No. 277 Yanta Road, Xi’an 710061, Shaanxi Province, China. bobwang457@sina.com
Key Words	Hepatectomy; Hepatitis B virus; Antiviral therapy; Hepatocellular carcinoma; Hepatitis B virus-DNA
Core Tip	Hepatocellular carcinoma (HCC) is the seventh most common cancer in the world and is usually associated with hepatitis B virus (HBV) infection. Radical resection and antiviral therapy are considered key clinical treatments for patients with HBV-related HCC. However, many patients have their HCC and HBV infection detected at the same time, so they receive remedial antiviral treatment beginning in the perioperative period, missing the opportunity for long-term preoperative antiviral therapy. Therefore, evaluating the clinical efficacy and relevant factors of perioperative remedial antiviral therapy will be valuable.
Publish Date	2024-05-09 13:59
Citation	Mu F, Hu LS, Xu K, Zhao Z, Yang BC, Wang YM, Guo K, Shi JH, Lv Y, Wang B. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome. World J Gastrointest Oncol 2024; 16(5): 1833-1848
URL	https://www.wjgnet.com/1948-5204/full/v16/i5/1833.htm
DOI	10.4251/wjgo.v16.i5.1833

Full Article (PDF)	WJGO-16-1833-with-cover.pdf
Manuscript File	90393_Auto_Edited-YJP.docx
Answering Reviewers	90393-Answering reviewers.pdf
Audio Core Tip	90393-Audio core tip.m4a
Biostatistics Review Certificate	90393-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	90393-Conflict-of-interest statement.pdf
Copyright License Agreement	90393-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	90393-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	90393-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	90393-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	90393-Language certificate.pdf
Peer-review Report	90393-Peer-review(s).pdf
Scientific Misconduct Check	90393-Bing-Fan JR-2.png
Scientific Editor Work List	90393-Scientific editor work list.pdf
CrossCheck Report	90393-CrossCheck report.pdf
CrossCheck Report	90393-CrossCheck.png